10 Interstitial Cystitis Clinical Trials in Omaha, NE (2026)

Q: How do I join a clinical trial in Omaha?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you.

Recruiting Interstitial Cystitis Studies in Omaha

NCT06057181Recruiting

Helix Research Network

The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-s...

Omaha, NE2,000,000 participantsHelix, Inc

View Study Details

NCT04005976Recruiting

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenoty...

Omaha, NE5,000 participantsThe University of Texas Health Science Center, Houston

View Study Details

NCT06085326Recruiting

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

The purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Improvement (QI) intervention to support beds...

Omaha, NENA3,000 participantsChildren's Hospital of Philadelphia

View Study Details

NCT06940232Recruiting

Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

The primary objective of this study is to establish if Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) are predictive of computed tomography (CT) findings in pedi...

Omaha, NE330 participantsUniversity of Nebraska

View Study Details

NCT07312734Recruiting

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is m...

Omaha, NE300 participantsChris Goss

View Study Details

NCT06217822Recruiting

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Researchers are looking for a better way to treat participants who have metastatic castration-resistant prostate cancer (mCRPC). mCRPC is a cancer of the prostate (male reproductive gland found below...

Omaha, NEPHASE1198 participantsBayer

View Study Details

NCT07581184Recruiting

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

This is a Phase 1b, multi-center, open-label study to evaluate the safety, tolerability, dosimetry, and pharmacokinetics (PK) of \[64Cu\]Cu-AKY-2519 and/or \[225Ac\]Ac-AKY-2519, as well as the prelimi...

Omaha, NEPHASE1138 participantsAktis Oncology, Inc.

View Study Details

NCT06879041Recruiting

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275....

Omaha, NEPHASE1136 participantsAstraZeneca

View Study Details

NCT06710756Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation Protein (FAP)-positive....

Omaha, NEPHASE1112 participantsPerspective Therapeutics

View Study Details

NCT05283330Recruiting

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

A Phase 1 Open-Label, First-in-human, Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, Pharmacokinetics, and Preliminary Efficacy of 212Pb-DOTAM-GRPR1 in Adult Par...

Omaha, NEPHASE148 participantsOrano Med Theranostics, SAS

View Study Details

About Interstitial Cystitis Clinical Trials in Omaha

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 10 interstitial cystitis clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 2,009,262 participants. Research is being sponsored by Helix, Inc, The University of Texas Health Science Center, Houston, Children's Hospital of Philadelphia and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Omaha — FAQ

Are there interstitial cystitis clinical trials in Omaha?

Yes, there are 10 interstitial cystitis clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Omaha?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.

Are clinical trials in Omaha free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 10 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 18, 2026 from ClinicalTrials.gov